Page 86 - 《中国药房》2024年19期
P. 86

对不同年龄稳定期慢性阻塞性肺疾病患者的病情评估                             COPD[J]. Chin J Lung Dis Electron Ed,2021,14(3):315-
               [J]. 北京医学,2022,44(6):485-489.                       317[2024-01-04]. https://zhfbjbzz.cma-cmc.com.cn/CN/
               GAO B,GUO J,LI N,et al. Evaluation of chronic obstruc‐  10.3877/cma.j.issn.1674-6902.2021.03.012. DOI:10.3877/
               tive  pulmonary  disease  assessment  test  questionnaire  in   cma.j.issn.1674-6902.2021.03.012.
               stable  chronic  obstructive  pulmonary  disease  patients  of   [14]  韩淑贞,董磊,李登峰. 白葡奈氏菌片联合布地奈德雾化
               different ages[J]. Beijing Med J,2022,44(6):485-489.  吸入治疗小儿急性肺炎的临床疗效[J]. 新疆医科大学学
          [ 9 ]  孟现玲,何玉廷,毛若琳,等 . 圣乔治呼吸问卷、CAT 及                     报,2024,47(3):355-359.
               mMRC 评分在慢性阻塞性肺病中的应用[J]. 复旦学报                        HAN S Z,DONG L,LI D F. Clinical effect of Staphylo‐
              (医学版),2022,49(6):862-868,876.                        coccus  and  Neisseria  tablets  combined  with  budesonide
               MENG X L,HE Y T,MAO R L,et al. Application of St    aerosol inhalation in treatment of acute pneumonia (AP)
               George’s  respiratory  questionnaire,CAT  and  mMRC  in   in  children[J].  J  Xinjiang  Med  Univ,2024,47(3):
               chronic  obstructive  pulmonary  disease[J].  Fudan  Univ  J   355-359.
               Med Sci,2022,49(6):862-868,876.                [15]  范存永,宋志明,张涵. 白葡奈氏菌片与新活素联合治疗
          [10]  孙印,何士杰,景卫革,等. 慢性阻塞性肺疾病免疫发病                         慢性肺源性心脏病急性发作的疗效及安全性[J]. 海南医
               机制研究进展[J]. 医学综述,2019,25(13):2574-2578.              学,2023,34(17):2454-2459.
               SUN Y,HE S J,JING W G,et al. Advances in research on   FAN C Y,SONG Z M,ZHANG H. Efficacy and safety of
               immune  pathogenesis  of  chronic  obstructive  pulmonary   the  combination  of  Staphylococcus  and  Neisseria  tablets
               disease[J]. Med Recapitul,2019,25(13):2574-2578.    and natriuretic peptide in the treatment of acute exacerba‐
          [11]  党辉,陈军,杨菲菲,等 . ACBT 联合 HRR 对稳定期                     tion of chronic pulmonary heart disease[J]. Hainan Med J,
               COPD 肺功能及运动能力的影响[J]. 中华肺部疾病杂                        2023,34(17):2454-2459.
               志(电子版),2023,16(5):667-669[2024-01-04]. https://  [16]  KEERATICHANANONT   W, KAENMUANG      P,
               zhfbjbzz.cma-cmc.com.cn/CN/10.3877/cma.j.issn.1674-  GEATER S L,et al. Correlation of fractional exhaled ni‐
               6902.2023.05.014. DOI:10.3877/cma.j.issn.1674-6902.  tric oxide (FeNO) and clinical outcomes in patients with
               2023.05.014.                                        chronic  obstructive  pulmonary  disease:a  prospective  co‐
               DANG H,CHEN J,YANG F F,et al. Effect of active re‐  hort study[J]. Respir Med,2024,229:107682.
               spiratory circulation technique combined with HRR reha‐  [17]  ELLINGSEN J,JANSON C,BRÖMS K,et al. CRP,fi‐
               bilitation exercise on pulmonary function and exercise ca‐  brinogen,white blood cells,and blood cell indices as prog‐
               pacity in patients with stable COPD[J]. Chin J Lung Dis   nostic  biomarkers  of  future  COPD  exacerbation  fre‐
               Electron Ed,2023,16(5):667-669[2024-01-04]. https://  quency:the  TIE  cohort  study[J].  J  Clin  Med,2024,13
               zhfbjbzz.cma-cmc.com.cn/CN/10.3877/cma.j.issn.1674-  (13):3855.
               6902.2023.05.014. DOI:10.3877/cma.j.issn.1674-6902.  [18]  JUNG A L,HAN M,GRISS K,et al. Novel protein bio‐
               2023.05.014.                                        markers for pneumonia and acute exacerbations in COPD:
          [12]  中华医学会呼吸病学分会慢性阻塞性肺疾病学组,中国                           a  pilot  study[J].  Front  Med (Lausanne),2023,10:
               医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会.                            1180746.
               慢性阻塞性肺疾病诊治指南:2021年修订版[J]. 中华结                  [19]  RAN B,QIN J Y,WU Y Q,et al. Causal role of immune
               核和呼吸杂志,2021,44(3):170-205.                          cells in chronic obstructive pulmonary disease:Mendelian
               Chronic  Obstructive  Pulmonary  Disease  Group  of  the    randomization study[J]. Expert Rev Clin Immunol,2024,
               Chinese  Thoracic  Society,Chronic  Obstructive  Pulmo‐  20(4):413-421.
               nary Disease Working Committee of the Chest Physicians   [20]  KHERADMAND F,ZHANG Y,CORRY D B. Contribu‐
               Branch of the Chinese Medical Doctor Association. Guide‐  tion  of  adaptive  immunity  to  human  COPD  and  experi‐
               lines  for  the  diagnosis  and  management  of  chronic  ob‐  mental models of emphysema[J]. Physiol Rev,2023,103
               structive  pulmonary  disease:revised  version  2021[J].   (2):1059-1093.
               Chin J Tuberc Respir Dis,2021,44(3):170-205.   [21]  UNNINAYAR D,SHEA B,CAMERON D W,et al. Le-
          [13]  娄红超,谢汉华,卢乃棉. 泛福舒对老年COPD患者的肺                        vels of immunoglobulin isotypes in serum and respiratory
               功能和细胞免疫力的分析[J]. 中华肺部疾病杂志(电子                         samples  of  patients  with  chronic  obstructive  pulmonary
               版),2021,14(3):315-317[2024-01-04]. https://zhfbjbzz.  disease:protocol  for  a  systematic  review  and  meta-
               cma-cmc.com.cn/CN/10.3877/cma.j.issn.1674-6902.2021.  analysis[J]. BMJ Open,2023,13(2):e064307.
               03.012. DOI:10.3877/cma.j.issn.1674-6902.2021.03.012.        (收稿日期:2024-02-05  修回日期:2024-09-08)
               LOU  H  C,XIE  H  H,LU  N  M. Analysis  of  pulmonary                              (编辑:胡晓霖)
               function and the cellular immunity in elderly patients with



          · 2396 ·    China Pharmacy  2024 Vol. 35  No. 19                            中国药房  2024年第35卷第19期
   81   82   83   84   85   86   87   88   89   90   91